Calcium and Vitamin D in Obesity and Related Chronic Disease

Advances in Food and Nutrition Research

Volumn 77, Issue , 2016, Pages 57-100

  Pannu, Poonam K ^a   Calton, Emily K ^a   Soares, Mario J ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

25(OH)D; Calcium; Endothelial function; Inflammation; Obesity; Type 2 diabetes; Vitamin D

Indexed keywords

CALCIUM; CALCIUM INTAKE; LIPID; VITAMIN D;

ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC DISEASE; DEFICIENCY; DIET; DYSLIPIDEMIA; EATING; ENERGY METABOLISM; FECES; HUMAN; INFLAMMATION; LIFESTYLE; LIPID METABOLISM; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; THERMOGENESIS; VASCULAR ENDOTHELIUM; VITAMIN D DEFICIENCY; WEIGHT REDUCTION;

ADIPOSE TISSUE; CALCIUM; CALCIUM, DIETARY; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIET; DYSLIPIDEMIAS; EATING; ENDOTHELIUM, VASCULAR; ENERGY METABOLISM; FECES; HUMANS; INFLAMMATION; LIFE STYLE; LIPID METABOLISM; LIPIDS; OBESITY; OXIDATION-REDUCTION; THERMOGENESIS; VITAMIN D; VITAMIN D DEFICIENCY; WEIGHT LOSS;

EID: 84959145120     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.afnr.2015.11.001     Document Type: Chapter

References (200)

1. Adamczak D.M., Nowak J.K., Frydrychowicz M., Kaczmarek M., Sikora J. The role of toll-like receptors and vitamin D in diabetes mellitus type 1-A review. Scandinavian Journal of Immunology 2014, 80(2):75-84.
2. Akash M.S., Rehman K., Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry 2013, 114(3):525-531.
3. Alyami A., Soares M.J., Sherriff J.L., Mamo J.C. Vitamin D and endothelial function. Indian Journal of Medical Research 2014, 140(4):483-490.
4. Anderson J.W., Kendall C.W.C., Jenkins D.J.A. Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies. Journal of the American College of Nutrition 2003, 22(5):331-339.
5. Arnson Y., Itzhaky D., Mosseri M., Barak V., Tzur B., Agmon-Levin N., et al. Vitamin D inflammatory cytokines and coronary events: A comprehensive review. Clinical Reviews in Allergy and Immunology 2013, 45(2):236-247.
6. Asemi Z., Foroozanfard F., Hashemi T., Bahmani F., Jamilian M., Esmaillzadeh A. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clinical Nutrition 2015, 34(4):586-592.
7. Asemi Z., Saneei P., Sabihi S.S., Feizi A., Esmaillzadeh A. Total, dietary, and supplemental calcium intake and mortality from all-causes, cardiovascular disease, and cancer: A meta-analysis of observational studies. Nutrition, Metabolism, and Cardiovascular Diseases 2015, 25(7):623-634.
8. Astrup A., Chaput J.P., Gilbert J.A., Lorenzen J.K. Dairy beverages and energy balance. Physiology and Behavior 2010, 100(1):67-75.
9. Barac A., Campia U., Panza J.A. Methods for evaluating endothelial function in humans. Hypertension 2007, 49(4):748-760.
10. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. The American Journal of Clinical Nutrition 2006, 84:18-28.
11. Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: Perspectives from mice and man. Journal of Bone and Mineral Research 2008, 23(7):974-979.
12. Bouillon R., Carmeliet G., Lieben L., Watanabe M., Perino A., Auwerx J., et al. Vitamin D and energy homeostasis-Of mice and men. Nature Reviews Endocrinology 2014, 10(2):79-87.
13. Breslavsky A., Frand J., Matas Z., Boaz M., Barnea Z., Shargorodsky M. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clinical Nutrition 2013, 32(6):970-975.
14. Buttari B., Profumo E., Segoni L., D'Arcangelo D., Rossi S., Facchiano F., et al. Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: Potential therapeutic implications in atherosclerosis. Oxidative Medicine and Cellular Longevity 2014, 2014:1-12.
15. Calton E.K., James A.P., Pannu P.K., Soares M.J. Certain dietary patterns are beneficial for the metabolic syndrome: Reviewing the evidence. Nutrition Research 2014, 34:559-568.
16. Calton E.K., Keane K.N., Soares M.J. The potential regulatory role of vitamin D in the bioenergetics of inflammation. Current Opinion in Clinical Nutrition and Metabolic Care 2015, 18(4):367-373.
17. Calton E.K., Pathak K., Soares M.J., Alfonso H., Keane K.N., Newsholme P., et al. Vitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults. European Journal of Nutrition 2015, 10.1007/s00394-015-1021-z.
18. Cantorna M.T., Snyder L., Lin Y.D., Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients 2015, 7(4):3011-3021.
19. Caron-Jobin M., Morisset A.S., Tremblay A., Huot C., Legare D., Tchernof A. Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring) 2011, 19(7):1335-1341.
20. Cavalier E., Delanaye P., Souberbielle J.C., Radermecker R.P. Vitamin D and type 2 diabetes mellitus: Where do we stand?. Diabetes and Metabolism 2011, 37(4):265-272.
21. Chan She-Ping-Delfos W., Soares M.J. Diet-induced thermogenesis, fat oxidation and food intake following sequential meals: Influence of calcium and vitamin D. Clinical Nutrition 2011, 30(3):376-383.
22. Chandler P.D., Scott J.B., Drake B.F., Ng K., Manson J.E., Rifai N., et al. Impact of vitamin D supplementation on inflammatory markers in African Americans: Results of a four-arm, randomized, placebo-controlled trial. Cancer Prevention Research (Philadelphia) 2014, 7(2):218-225.
23. Cheng S., Massaro J.M., Fox C.S., Larson M.G., Keyes M.J., McCabe E.L., et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes 2010, 59(1):242-248.
24. Chiu K.C., Chu A., Go V.L.W., Saad M.F. Hypovitaminosis D is associated with insulin resistance β cell dysfunction. The American Journal of Clinical Nutrition 2004, 79:820-825.
25. Chiu K.C., Cohan P., Lee N.P., Chuang L.M. Insulin sensitivity differs among ethnic groups with a compensatory response β-cell function. Diabetes Care 2000, 23:1353-1358.
26. Chonchol M., Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney International 2007, 71(2):134-139.
27. Christensen P., Bartels E.M., Riecke B.F., Bliddal H., Leeds A.R., Astrup A., et al. Improved nutritional status and bone health after diet-induced weight loss in sedentary osteoarthritis patients: A prospective cohort study. European Journal of Clinical Nutrition 2012, 66(4):504-509.
28. Colditz G.A., Manson J.E., Stampfer M.J., Rosner B., Willett W.C., Speizer F.E. Diet and risk of clinical diabetes in women. The American Journal of Clinical Nutrition 1992, 55:1018-1023.
29. Cummings N.K., James A.P., Soares M.J. The acute effects of different sources of dietary calcium on postprandial energy metabolism. The British Journal of Nutrition 2006, 96(1):138-144.
30. D'Aurizio F., Villalta D., Metus P., Doretto P., Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?. Autoimmunity Reviews 2015, 14(5):363-369.
31. Del Gobbo L.C., Song Y., Dannenbaum D.A., Dewailly E., Egeland G.M. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. The Journal of Nutrition 2011, 141(2):290-295.
32. Di Rosa M., Malaguarnera G., De Gregorio C., Palumbo M., Nunnari G., Malaguarnera L. Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cellular Immunology 2012, 280(1):36-43.
33. Ding C., Gao D., Wilding J., Trayhurn P., Bing C. Vitamin D signalling in adipose tissue. The British Journal of Nutrition 2012, 108(11):1915-1923.
34. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology 2011, 11(2):98-107.
35. Dougkas A., Reynolds C.K., Givens I.D., Elwood P.C., Minihane A.M. Associations between dairy consumption and body weight: A review of the evidence and underlying mechanisms. Nutrition Research Reviews 2011, 24(1):72-95.
36. Drincic A.T., Armas L.A., Van Diest E.E., Heaney R.P. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012, 20(7):1444-1448.
37. Dunnigan M.G., Harland W.A., Fyfe T. Seasonal incidence and mortality of ischaemic heart disease. The Lancet 1970, 296(7677):793-797.
38. Enos R.T., Davis J.M., Velazquez K.T., McClellan J.L., Day S.D., Carnevale K.A., et al. Influence of dietary saturated fat content on adiposity, macrophage behavior, inflammation, and metabolism: Composition matters. The Journal of Lipid Research 2013, 54:152-163.
39. Facchini L., Venturini E., Galli L., Martino M., Chiappini E. Vitamin D and tuberculosis: A review on a hot topic. Journal of Chemotherapy 2015, 27(3):128-138.
40. Ferrannini E. The theoretical bases of indirect calorimetry: A review. Metabolism, Clinical and Experimental 1988, 37(3):287-301.
41. Ferrannini E. Insulin resistance versus insulin deficiency in noninsulin-dependent diabetes mellitus: Problems and prospects. Endocrine Reviews 1998, 19(4):477-490.
42. Flatt J. Use and storage of carbohydrate and fat. The American Journal of Clinical Nutrition 1995, 61(suppl.):952S-959S.
43. Flint A., Gregersen N.T., Gluud L.L., Moller B.K., Raben A., Tetens I., et al. Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: A meta-analysis of test meal studies. The British Journal of Nutrition 2007, 98(1):17-25.
44. Flores M. A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?. Nutrition Research Reviews 2005, 18(2):175-182.
45. Florez J.C. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes. Diabetologia 2008, 51:1100-1110.
46. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49(5):1063-1069.
47. Forouhi N.G., Luan J., Cooper A., Boucher B.J., Wareham N.J. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57(10):2619-2625.
48. Frostegard J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145(1):33-43.
49. Gallagher J.C., Yalamanchili V., Smith L.M. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. The Journal of Steroid Biochemistry and Molecular Biology 2013, 136:195-200.
50. George P.S., Pearson E.R., Witham M.D. Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis. Diabetic Medicine 2012, 29(8):e142-e150.
51. Gepner A.D., Ramamurthy R., Krueger D.C., Korcarz C.E., Binkley N., Stein J.H. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012, 7(5):e36617.
52. Gerich J.E. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocrine Reviews 1998, 19(4):491-503.
53. Gilbert J.A., Joanisse D.R., Chaput J.P., Miegueu P., Cianflone K., Almeras N., et al. Milk supplementation facilitates appetite control in obese women during weight loss: A randomised, single-blind, placebo-controlled trial. The British Journal of Nutrition 2011, 105(1):133-143.
54. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. Journal of the American Geriatrics Society 2009, 57(9):1595-1603.
55. Gonzalez J.T., Green B.P., Campbell M.D., Rumbold P.L., Stevenson E.J. The influence of calcium supplementation on substrate metabolism during exercise in humans: A randomized controlled trial. European Journal of Clinical Nutrition 2014, 68(6):712-718.
56. Gonzalez L., Ramos-Trautmann G., Diaz-Luquis G.M., Perez C.M., Palacios C. Vitamin D status is inversely associated with obesity in a clinic-based sample in Puerto Rico. Nutrition Research 2015, 35(4):287-293.
57. Gonzalez J.T., Rumbold P.L., Stevenson E.J. Effect of calcium intake on fat oxidation in adults: A meta-analysis of randomized, controlled trials. Obesity Reviews 2012, 13(10):848-857.
58. Goodman D.S., Hulley S.B., Clark L.T., et al. Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Archives of Internal Medicine 1988, 148(1):36-69.
59. Goral A., Brola W., Kasprzyk M., Przybylski W. The role of vitamin D in the pathogenesis and course of multiple sclerosis. Wiadomości Lekarskie 2015, 68(1):60-66.
60. Gujral U.P., Narayan K.M., Kahn S.E., Kanaya A.M. The relative associations of beta-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: The MASALA study. Journal of Diabetes and Its Complications 2014, 28(1):45-50.
61. Gunther C.W., Legowski P.A., Lyle R.M., McCabe G.P., Eagan M., Peacock M., et al. Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. The American Journal of Clinical Nutrition 2005, 81:751-756.
62. Haththotuwa R.N., Wijeyaratne C.N., Senarath U. Worldwide epidemic of obesity. Obesity: A ticking time bomb for reproductive health 2013, 3-11. Elsevier, London, UK. T. Mahmood, S. Arulkumaran (Eds.).
63. Heaney R.P., Horst R.L., Cullen D.M., Armas L.A.G. Vitamin D3 distribution and status in the body. Journal of the American College of Nutrition 2009, 28(3):252-256.
64. Heaney R.P., Weaver C.M., Fitzsimmons M.L. Influence of calcium load on absorption fraction. Journal of Bone and Mineral Research 1990, 5(11):1135-1138.
65. Hill J.O., Wyatt H.R., Reed G.W., Peters J.C. Obesity and the environment: Where do we go from here?. Science 2003, 299(5608):853-855.
66. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 1996, 3(2):213-219.
67. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings 2006, 81(3):353-373.
68. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011, 96(7):1911-1930.
69. Holick M.F., Chen T.C. Vitamin D deficiency: A worldwide problem with health consequences. The American Journal of Clinical Nutrition 2008, 87(suppl.):1080S-1086S.
70. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism 2005, 90(6):3215-3224.
71. Hossein-Nezhad A., Mirzaei K., Keshavarz S.A., Ansar H., Saboori S., Tootee A. Evidences of dual role of vitamin D through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects. Minerva Medica 2013, 104(3):295-307.
72. Hsia J., Heiss G., Ren H., Allison M., Dolan N.C., Greenland P., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115(7):846-854.
73. Husemoen L.L.N., Thuesen B.H., Fenger M., Jorgensen T., Glumer C., Svensson J., et al. Serum 25(OH)D and type 2 diabetes association in a general population. Diabetes Care 2012, 35:1695-1700.
74. Ibero-Baraibar I., Navas-Carretero S., Abete I., Martinez J.A., Zulet M.A. Increases in plasma 25(OH)D levels are related to improvements in body composition and blood pressure in middle-aged subjects after a weight loss intervention: Longitudinal study. Clinical Nutrition 2014, 34(5):1010-1017.
75. Institute of Medicine Dietary reference intakes for calcium and vitamin D 2011, The National Academies Press, Washington, DC.
76. International Diabetes Federation IDF diabetes atlas 2013, International Diabetes Federation, Brussels, Belgium. 6th ed.
77. Ishida H., Suzuki K., Someya Y., Nishimura M., Sugimoto C., Goto M., et al. Possible compensatory role of parathyroid hormone-related peptide on maintenance of calcium homeostasis in patients with non-insulin-dependent diabetes mellitus. Acta Endocrinologica 1993, 129(6):519-524.
78. Jacobsen R., Lorenzen J.K., Toubro S., Krog-Mikkelsen I., Astrup A. Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. International Journal of Obesity 2005, 29(3):292-301.
79. Jain S.K., Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochemical and Biophysical Research Communications 2013, 437(1):7-11.
80. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiological Reviews 1998, 78(4):1193-1231.
81. Jorde R., Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Progress in Lipid Research 2011, 50(4):303-312.
82. Jorde R., Schirmer H., Wilsgaard T., Joakimsen R.M., Mathiesen E.B., Njolstad I., et al. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromso Study. PLoS One 2012, 7(5):e37295.
83. Kabrnová-Hlavatá K., Hainer V., Gojová M., Hlavaty P., Kopsky V., Nedvídková J., et al. Calcium intake and the outcome of short-term weight management. Physiological Research 2008, 57(2):237-245.
84. Kampmann U., Mosekilde L., Juhl C., Moller N., Christensen B., Rejnmark L., et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency-A double-blind, randomized, placebo-controlled trial. Metabolism, Clinical and Experimental 2014, 63(9):1115-1124.
85. Kassi E., Adamopoulos C., Basdra E.K., Papavassiliou A.G. Role of vitamin D in atherosclerosis. Circulation 2013, 128(23):2517-2531.
86. Kayaniyil S., Vieth R., Retnakaran R., Knight J.A., Qi Y., Gerstein H.C., et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010, 33(6):1379-1381.
87. Kendrick J., Targher G., Smits G., Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009, 205(1):255-260.
88. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., et al. Vitamin D, parathyroid hormone and cardiovascular events among older adults. Journal of the American College of Cardiology 2011, 58(14):1433-1441.
89. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). The American Journal of Cardiology 2008, 102(11):1540-1544.
90. Korf H., Decallonne B., Mathieu C. Vitamin D for infections. Current Opinion in Endocrinology, Diabetes, and Obesity 2014, 21(6):431-436.
91. Lips P. Worldwide status of vitamin D nutrition. Journal of Steroid Biochemistry and Molecular Biology 2010, 121(1-2):297-300.
92. Liu J. Vitamin D content of food and its contribution to vitamin D status: A brief overview and Australian focus. Photochemical & Photobiological Sciences 2012, 11(12):1802-1807.
93. 2 and plays an anti-inflammatory role in macrophages. Immunology 2014, 143(1):81-95.
94. Liu E., Meigs J.B., Pittas A.G., McKeown N.M., Economos C.D., Booth S.L., et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. The Journal of Nutrition 2009, 139(2):329-334.
95. Liu S., Song Y., Ford E.S., Manson J.E., Buring J.E., Ridker P.M. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005, 28(12):2926-2932.
96. Lorenzen J.K., Astrup A. Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. The British Journal of Nutrition 2011, 105(12):1823-1831.
97. Lorenzen J.K., Nielsen S., Holst J.J., Tetens I., Rehfeld J.F., Astrup A. Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. The American Journal of Clinical Nutrition 2007, 85:678-687.
98. Lu L., Yu Z., Pan A., Hu F.B., Franco O.H., Li H., et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009, 32(7):1278-1283.
99. Major G.C., Alarie F., Dore J., Phouttama S., Tremblay A. Supplementation with calcium+vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. The American Journal of Clinical Nutrition 2007, 85:54-59.
100. Major G.C., Alarie F.P., Doré J., Tremblay A. Calcium plus vitamin D supplementation and fat mass loss in female very low-calcium consumers: Potential link with a calcium-specific appetite control. The British Journal of Nutrition 2009, 101(05):659-663.
101. Maki K.C., Rubin M.R., Wong L.G., McManus J.F., Jensen C.D., Marshall J.W., et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. Journal of Clinical Lipidology 2009, 3(4):289-296.
102. Malmberg P., Karlsson T., Svensson H., Lonn M., Carlsson N.G., Sandberg A.S., et al. A new approach to measuring vitamin D in human adipose tissue using time-of-flight secondary ion mass spectrometry: A pilot study. Journal of Photochemistry and Photobiology 2014, 138:295-301.
103. Manousopoulou A., Al-Daghri N.M., Garbis S.D., Chrousos G.P. Vitamin D and cardiovascular risk among adults with obesity: A systematic review and meta-analysis. European Journal of Clinical Investigation 2015, 45(10):1113-1126.
104. Martinez J.A. Body-weight regulation: Causes of obesity. Proceedings of the Nutrition Society 2000, 59:227-345.
105. Mason C., Xiao L., Imayama I., Duggan C., Wang C.Y., Korde L., et al. Vitamin D3 supplementation during weight loss: A double-blind randomized controlled trial. The American Journal of Clinical Nutrition 2014, 99(5):1015-1025.
106. McCarron D.A., Morris C.D., Henry H.J., Stanton J.L. Blood pressure and nutrient intake in the United States. Science 1984, 224(4656):1392-1398.
107. Misra R., Patel T., Kotha P., Raji A., Ganda O., Banerji M., et al. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: Results from a national study. Journal of Diabetes and its Complications 2010, 24(3):145-153.
108. Mitri J., Muraru M.D., Pittas A.G. Vitamin D and type 2 diabetes: A systematic review. European Journal of Clinical Nutrition 2011, 65(9):1005-1015.
109. Montoya-Rodríguez A., de Mejía E.G., Dia V.P., Reyes-Moreno C., Milán-Carrillo J. Extrusion improved the anti-inflammatory effect of amaranth (Amaranthus hypochondriacus) hydrolysates in LPS-induced human THP-1 macrophage-like and mouse RAW 264.7 macrophages by preventing activation of NF-kappaB signaling. Molecular Nutrition & Food Research 2014, 58:1028-1041.
110. Mora N., Rieke K., Plitcha J., Segura A., Leehey D., DeShong K., et al. 25-Hydroxyvitamin D supplementation and BMI change: A meta-analysis of randomized controlled trials. Journal of Obesity and Weight Loss Therapy 2013, 3(4):181-199.
111. Muñoz-Aguirre P., Flores M., Macias N., Quezada A.D., Denova-Gutiérrez E., Salmerón J. The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial. Clinical Nutrition 2014, 34(5):799-804.
112. Narvaez C.J., Matthews D., Broun E., Chan M., Welsh J. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 2009, 150(2):651-661.
113. Neve A., Corrado A., Cantatore F. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clinical and Experimental Medicine 2013, 14(3):275-283.
114. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 2014, 384(9945):766-781.
115. Nigil Haroon N., Anton A., John J., Mittal M. Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes: A systematic review of interventional studies. Journal of Diabetes and Metabolic Disorders 2015, 14:3-1-11.
116. Ojaimi S., Skinner N.A., Strauss B.J.G., Sundararajan V., Woolley I., Visvanathan K. Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: A pilot study. Journal of Translational Medicine 2013, 11:176-183.
117. Onakpoya I.J., Perry R., Zhang J., Ernst E. Efficacy of calcium supplementation for management of overweight and obesity: Systematic review of randomized clinical trials. Nutrition Reviews 2011, 69(6):335-343.
118. Ortega R.M., Aparicio A., Rodriguez-Rodriguez E., Bermejo L.M., Perea J.M., Lopez-Sobaler A.M., et al. Preliminary data about the influence of vitamin D status on the loss of body fat in young overweight/obese women following two types of hypocaloric diet. The British Journal of Nutrition 2008, 100(2):269-272.
119. Pannu P.K., Zhao Y., Soares M.J. Reductions in body weight and percent fat mass increase the vitamin D status of obese subjects: A systematic review and meta-regression analysis. Nutrition Research 2015, 10.1016/j.nutres.2015.11.013.
120. Parish S., Offer A., Clarke R., Hopewell J.C., Hill M.R., Otvos J.D., et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation 2012, 125(20):2469-2478.
121. Pathak K., Soares M.J., Calton E.K., Zhao Y., Hallett J. Vitamin D supplementation and body weight status: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews 2014, 15(6):528-537.
122. Paula F.J.A., Lanna C.M.M., Shuhama T., Foss M.C. Effect of metabolic control on parathyroid hormone secretion in diabetic patients. Brazillian Journal of Medical and Biological Research 2001, 34:1139-1145.
123. Pertea M., Salzberg S.L. Between a chicken and a grape: Estimating the number of human genes. Genome Biology 2010, 11(5):206-213.
124. Peterlik M., Boonen S., Cross H.S., Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: An emerging world-wide public health problem. International Journal of Environmental Research and Public Health 2009, 6(10):2585-2607.
125. Pilz S., Gaksch M., Kienreich K., Grubler M., Verheyen N., Fahrleitner-Pammer A., et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial. Hypertension 2015, 65(6):1195-1201.
126. Pilz S., Kienreich K., Rutters F., de Jongh R., van Ballegooijen A.J., Grubler M., et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Current Diabetes Reports 2013, 13(2):261-270.
127. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., et al. Systematic review: Vitamin D and cardiometabolic outcomes. Annals of Internal Medicine 2010, 152:307-314.
128. Pittas A.G., Dawson-Hughes B., Li T., van Dam R.M., Willett W.C., Manson J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29:650-656.
129. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007, 92(6):2017-2029.
130. Ponda M.P., Dowd K., Finkielstein D., Holt P.R., Breslow J.L. The short-term effects of vitamin D repletion on cholesterol: A randomized, placebo-controlled trial. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32(10):2510-2515.
131. Procopio M., Borretta G. Derangement of glucose metabolism in hyperparathyroidism. Journal of Endocrinological Investigation 2003, 26:1136-1142.
132. Qin X.F., Zhao L.S., Chen W.R., Yin da W., Wang H. Effects of vitamin D on plasma lipid profiles in statin-treated patients with hypercholesterolemia: A randomized placebo-controlled trial. Clinical Nutrition 2015, 34(2):201-206.
133. Ralph A.P., Lucas R.M., Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. The Lancet Infectious Diseases 2013, 13(1):77-88.
134. Riedt C.S., Schlussel Y., von Thun N., Ambia-Sobhan H., Stahl T., Field M.P., et al. Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. The American Journal of Clinical Nutrition 2007, 85:972-980.
135. Rosenblum J.L., Castro V.M., Moore C.E., Kaplan L.M. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. The American Journal of Clinical Nutrition 2012, 95(1):101-108.
136. Rosenstreich S.J., Rich C., Volwiler W. Deposition in and release of vitamin D3 from body fat: Evidence for a storage site in the rat. The Journal of Clinical Investigation 1971, 50:679-687.
137. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993, 362(6423):801-809.
138. Rueda S., Fernandez-Fernandez C., Romero F., de Osaba J.M., Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obesity Surgery 2008, 18:151-154.
139. Ryu O.H., Chung W., Lee S., Hong K.S., Choi M.G., Yoo H.J. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. The Korean Journal of Internal Medicine 2014, 29(5):620-629.
140. Sadiya A., Ahmed S.M., Carlsson M., Tesfa Y., George M., Ali S.H., et al. Vitamin D supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial. Clinical Nutrition 2015, 1-6.
141. Salehpour A., Shidfar F., Hosseinpanah F., Vafa M., Razaghi M., Hoshiarrad A., et al. Vitamin D3 and the risk of CVD in overweight and obese women: A randomised controlled trial. The British Journal of Nutrition 2012, 108(10):1866-1873.
142. Schnatz P.F., Jiang X., Vila-Wright S., Aragaki A.K., Nudy M., O'Sullivan D.M., et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause 2014, 21(8):823-833.
143. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care 2004, 27(12):2813-2818.
144. Seida J.C., Mitri J., Colmers I.N., Majumdar S.R., Davidson M.B., Edwards A.L., et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: A systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism 2014, 99(10):3551-3560.
145. 2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochemical and Biophysical Research Communications 2009, 384(1):18-21.
146. Shapses S.A., Heshka S., Heymsfield S.B. Effect of calcium supplementation on weight and fat loss in women. Journal of Clinical Endocrinology and Metabolism 2004, 89:632-637.
147. Sharifi N., Amani R., Hajiani E., Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 2014, 47(1):70-80.
148. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010, 87(1):4-14.
149. Shi H., Norman A.W., Okamura W.H., Sen A., Zemel M.B. 1α,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. The FASEB Journal 2001, 15(14):2751-2753.
150. Smilowitz J.T., Wiest M.M., Teegarden D., Zemel M.B., German J.B., Van Loan M.D. Dietary fat and not calcium supplementation or dairy product consumption is associated with changes in anthropometrics during a randomized, placebo-controlled energy-restriction trial. Nutrition & Metabolism 2011, 8:67-1-10.
151. Soares M.J., Chan She Ping-Delfos W., Ghanbari M.H. Calcium and vitamin D for obesity: A review of randomized controlled trials. European Journal of Clinical Nutrition 2011, 65(9):994-1004.
152. Soares M.J., Murhadi L.L., Kurpad A.V., Chan She Ping-Delfos W.L., Piers L.S. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obesity Reviews 2012, 13(7):592-605.
153. Soares M.J., Ping-Delfos W.C., Sherriff J.L., Nezhad D.H., Cummings N.K., Zhao Y. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: Cause or effect?. European Journal of Clinical Nutrition 2011, 65(12):1348-1352.
154. Soerensen K.V., Thorning T.K., Astrup A., Kristensen M., Lorenzen J.K. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. The American Journal of Clinical Nutrition 2014, 99(5):984-991.
155. Sokol S.I., Srinivas V., Crandall J.P., Kim M., Tellides G., Lebastchi A., et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vascular Medicine 2012, 17(6):394-404.
156. Sollid S.T., Hutchinson M.Y., Fuskevag O.M., Figenschau Y., Joakimsen R.M., Schirmer H., et al. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 2014, 37(8):2123-2131.
157. Song Q., Sergeev I.N. Calcium and vitamin D in obesity. Nutrition Research Reviews 2012, 25(1):130-141.
158. Song Y., Wang L., Pittas A.G., Del Gobbo L.C., Zhang C., Manson J.E., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes. Diabetes Care 2013, 36:1422-1428.
159. Soon J., Tee E. Changing trends in dietary pattern and implications to food and nutrition security in association of Southeast Asian nations (ASEAN). International Journal of Food and Nutrition Sciences 2014, 3:259-269.
160. Stricker H., Bianda F.T., Guidicelli-Nicolosi S., Limoni C., Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: A randomised controlled pilot study. European Journal of Vascular and Endovascular Surgery 2012, 44(3):307-312.
161. Tabesh M., Azadbakht L., Faghihimani E., Tabesh M., Esmaillzadeh A. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: A randomised controlled clinical trial. Diabetologia 2015, 57(10):2038-2047.
162. Takiishi T., Gysemans C., Bouillon R., Mathieu C. Vitamin D and diabetes. Endocrinology and Metabolism Clinics of North America 2010, 39(2):419-446.
163. Taylor W.H., Khaleeli A.A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabetic Medicine 1997, 14:386-389.
164. Teegarden D., White K.M., Lyle R.M., Zemel M.B., Van Loan M.D., Matkovic V., et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity 2008, 16(7):1566-1572.
165. Thomas D.T., Wideman L., Lovelady C.A. Effects of calcium and resistance exercise on body composition in overweight premenopausal women. Journal of the American College of Nutrition 2010, 29(6):604-611.
166. Tordoff M.G. Calcium: Taste, intake, and appetite. Physiological Reviews 2001, 81(4):1567-1597.
167. Tousoulis D., Antoniades C., Stefanadis C. Evaluating endothelial function in humans: A guide to invasive and non-invasive techniques. Heart 2005, 91(4):553-558.
168. Tran B., Armstrong B.K., McGeechan K., Ebeling P.R., English D.R., Kimlin M.G., et al. Predicting vitamin D deficiency in older Australian adults. Clinical Endocrinology 2013, 79(5):631-640.
169. Trowman R., Dumville J.C., Hahn S., Torgerson D.J. A systematic review of the effects of calcium supplementation on body weight. The British Journal of Nutrition 2007, 95(06):1033-1038.
170. Tulk S.E., Liao K.C., Muruve D.A., Li Y., Beck P.L., MacDonald J.A. Vitamin D(3) metabolites enhance the NLRP3-dependent secretion of IL-1beta from human THP-1 monocytic cells. Journal of Cellular Biochemistry 2015, 116(5):711-720.
171. van Dam R.M., Hu F.B., Rosenberg L., Krishnan S., Palmer J.R. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care 2006, 29(10):2238-2243.
172. Vimaleswaran K.S., Cavadino A., Berry D.J., Jorde R., Dieffenbach A.K., Lu C., et al. Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study. The Lancet Diabetes & Endocrinology 2014, 2(9):719-729.
173. von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-A randomised, placebo-controlled trial. The British Journal of Nutrition 2010, 103(4):549-555.
174. Wamberg L., Christiansen T., Paulsen S.K., Fisker S., Rask P., Rejnmark L., et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue-The effect of obesity and diet-induced weight loss. International Journal of Obesity 2013, 37(5):651-657.
175. Wamberg L., Kampmann U., Stodkilde-Jorgensen H., Rejnmark L., Pedersen S.B., Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-Results from a randomized trial. European Journal of Internal Medicine 2013, 24(7):644-649.
176. Wang Y.C., Hsieh C.C., Kuo H.F., Tsai M.K., Yang S.N., Kuo C.H., et al. Effect of vitamin D-3 on monocyte chemoattractant protein 1 production in monocytes and macrophages. Acta Cardiologica Sinica 2014, 30(2):144-150.
177. Wang Y., Li S. Worldwide trends in dairy production and consumption and calcium intake: Is promoting consumption of dairy products a sustainable solution for inadequate calcium intake?. Food and Nutrition Bulletin 2008, 29(3):172-185.
178. Wang J., Lv S., Chen G., Gao C., He J., Zhong H., et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients 2015, 7(4):2485-2498.
179. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
180. Wang H., Xia N., Yang Y., Peng D.Q. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids in Health and Disease 2012, 11(42):1-9.
181. Witham M.D., Dove F.J., Khan F., Lang C.C., Belch J.J., Struthers A.D. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction-A randomised controlled trial. International Journal of Cardiology 2013, 167(3):745-749.
182. Witham M.D., Price R.J., Struthers A.D., Donnan P.T., Messow C.M., Ford I., et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: The VitDISH randomized controlled trial. JAMA Internal Medicine 2013, 173(18):1672-1679.
183. Wong K.E., Kong J., Zhang W., Szeto F.L., Ye H., Deb D.K., et al. Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. The Journal of Biological Chemistry 2011, 286(39):33804-33810.
184. Wong K.E., Szeto F.L., Zhang W., Ye H., Kong J., Zhang Z., et al. Involvement of the vitamin D receptor in energy metabolism: Regulation of uncoupling proteins. American Journal of Physiology, Endocrinology and Metabolism 2009, 296(4):E820-E828.
185. Wood A.D., Secombes K.R., Thies F., Aucott L., Black A.J., Mavroeidi A., et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: A parallel-group, double-blind, placebo-controlled RCT. The Journal of Clinical Endocrinology and Metabolism 2012, 97(10):3557-3568.
186. Woodman R.J., Watts G.F. Measurement and application of arterial stiffness in clinical research: Focus on new methodologies and diabetes mellitus. Medical Science Monitor 2003, 9(5):Ra81-Ra89.
187. Worstman J., Matsuoka L.Y., Chen C.T., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. The American Journal of Clinical Nutrition 2000, 72:690-693.
188. Yang M.X., Shen Z.N., Chen D.Y., Gan H., Shen Q., Yang B., et al. Effects of 1,25-(OH)(2)D-3 on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia. Inflammation Research 2012, 61(5):511-520.
189. Yiu Y.F., Yiu K.H., Siu C.W., Chan Y.H., Li S.W., Wong L.Y., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227(1):140-146.
190. Young K.A., Engelman C.D., Langefeld C.D., Hairston K.G., Haffner S.M., Bryer-Ash M., et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. The Journal of Clinical Endocrinology and Metabolism 2009, 94(9):3306-3313.
191. Zehnder D., Bland R., Chana R.S., Wheeler D.C., Howie A.J., Williams M.C., et al. Synthesis of 1,25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: A novel autocrine determinant of vascular cell adhesion. Journal of the American Society of Nephrology 2002, 13(3):621-629.
192. Zemel M.B. Nutritional and endocrine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension. Molecular and Cellular Biochemistry 1998, 188:129-136.
193. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. The FASEB Journal 2000, 14:1132-1138.
194. Zemel M.B., Sun X. Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. The Journal of Nutrition 2008, 138(6):1047-1052.
195. Zemel M.B., Thompson W., Milstead A., Morris K., Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obesity Research 2004, 12(4):582-590.
196. Zhang Y., Leung D.Y.M., Goleva E. Vitamin D enhances glucocorticoid action in human monocytes. Involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. Journal of Biological Chemistry 2013, 288(20):14544-14553.
197. Zhang Y., Leung D.Y., Richers B.N., Liu Y., Remigio L.K., Riches D.W., et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. Journal of Immunology 2012, 188(5):2127-2135.
198. Zhu W., Cai D., Wang Y., Lin N., Hu Q., Qi Y., et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: A randomized controlled trial. Nutrition Journal 2013, 12:8.
199. Zhu B., Zhao H.L., Ou C., Huang L.S., Li P.Z., Lao M. Association of vitamin D receptor BsmI gene polymorphism with the risk of type 2 diabetes mellitus. Journal of Receptor and Signal Transduction Research 2014, 34(6):458-462.
200. Soares M.J., Pathak K., Calton E.K. Calcium and vitamin D in the regulation of energy balance: Where do we stand?. International Journal of Molecular Sciences 2014, 15(3):4938-4945. 10.3390/ijms15034938.